ArticleJMIR public health and surveillance2020

Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point.

Moshe Rogosnitzky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.